Your browser doesn't support javascript.
loading
Pityriasis Rubra Pilaris: A Multicentric Case Series of 65 Spanish Patients.
Montero-Menárguez, J; Amat Samaranch, V; Puig Sanz, L; Ruiz-Villaverde, R; Arias-Santiago, S; Larrea García, M; Ruiz Genao, D; Ferrán, M; Schneller-Pavelescu, L; Romero Ferreiro, C; Rivera Díaz, R.
Afiliação
  • Montero-Menárguez J; Dermatology Department of the Hospital Universitario 12 de Octubre, Madrid, Spain. Electronic address: julia.montero.menarguez@gmail.com.
  • Amat Samaranch V; Dermatology Department of Hospital de la Santa Creu i Sant Pau de Barcelona, Spain.
  • Puig Sanz L; Dermatology Department of Hospital de la Santa Creu i Sant Pau de Barcelona, Spain.
  • Ruiz-Villaverde R; Dermatology Department of Hospital Universitario San Cecilio de Granada, Spain.
  • Arias-Santiago S; Dermatology Department of Hospital Virgen de las Nieves de Granada, School of Medicine, Granada University, Instituto de Investigación Biosanitaria IBS, Granada, Spain.
  • Larrea García M; Dermatology Department of Hospital Universitario de Navarra, Spain.
  • Ruiz Genao D; Dermatology Department of Fundación Hospital Alcorcón, Spain.
  • Ferrán M; Dermatology Department of Hospital del Mar de Barcelona, Spain.
  • Schneller-Pavelescu L; Dermatology Department of Hospital de la Vega Baja de Alicante, Spain.
  • Romero Ferreiro C; Unidad de Soporte Científico, Instituto de Investigación Sanitaria, Hospital Universitario 12 de Octubre, Spain; Facultad de Ciencias de la Salud, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Madrid, Spain.
  • Rivera Díaz R; Dermatology Department of the Hospital Universitario 12 de Octubre, Madrid, Spain.
Actas Dermosifiliogr ; 2024 Feb 22.
Article em En, Es | MEDLINE | ID: mdl-38401879
ABSTRACT

INTRODUCTION:

PRP is a rare entity of unknown etiopathogenesis. Lack of management guidelines makes it a challenge for clinicians.

OBJECTIVE:

To add our experience to increase evidence about PRP.

METHODS:

We performed a retrospective, descriptive and multicentric study of 65 patients with PRP, being the largest European case series of patients with PRP.

RESULTS:

PRP was more frequent in male patients with an average age of 51 years, but erythrodermic forms presented in older patients (average age 61 years). Six (75%) paediatric patients and ten (60%) non-erythrodermic adults controlled their disease with topical corticosteroids. On the contrary, 26 (68%) erythrodermic patients required biologic therapy as last and effective therapy line requiring an average of 6.5 months to achieve complete response.

CONCLUSION:

Our study showed a statistical difference in terms of outcome and response to treatment between children or patients with limited disease and patients who develop erythroderma.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En / Es Revista: Actas Dermosifiliogr Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En / Es Revista: Actas Dermosifiliogr Ano de publicação: 2024 Tipo de documento: Article